Samaritan Pharmaceuticals Begins Trading On OTC Bulletin Board Under Ticker Symbol SPHC
December 17, 2007 10:10 ET
|
Samaritan Pharmaceuticals, Inc.
LAS VEGAS, Dec. 17, 2007 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals, Inc. (OTCBB:SPHC) (http://www.samaritanpharma.com), a biopharmaceutical company focused on developing innovative therapeutics in...
Samaritan Pharmaceuticals to Trade On OTC Bulletin Board
December 13, 2007 10:23 ET
|
Samaritan Pharmaceuticals, Inc.
LAS VEGAS, Dec. 13, 2007 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals, Inc. (AMEX:LIV) (https://www.samaritanpharma.com), announces that it is seeking to have its common stock trade under a new stock...
Samaritan Pharma Retains The Investor Relations Group of New York
December 04, 2007 10:51 ET
|
Samaritan Pharmaceuticals, Inc.
LAS VEGAS, Dec. 4, 2007 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals, Inc. (AMEX:LIV) (http://www.samaritanpharma.com), a biopharmaceutical company focused on developing innovative therapeutics in...
Samaritan Presents Favorable Caprospinol Data At Alzheimer's Drug Development Summit November 30
November 27, 2007 09:23 ET
|
Samaritan Pharmaceuticals, Inc.
Conference Showcases the Latest Disease Modifying Therapies and
Pre-Symptomatic Approaches for Alzheimer's Drug Development
Dr. Lecanu to Present Favorable Caprospinol Data Showing the Clearing
...
Samaritan Announces Update on Pharmaplaz Funding
November 09, 2007 17:45 ET
|
Samaritan Pharmaceuticals, Inc.
LAS VEGAS, Nov. 9, 2007 (PRIME NEWSWIRE) -- LAS VEGAS November 9, 2007--Samaritan Pharmaceuticals, Inc. (AMEX:LIV) announces that on October 16, 2007, Samaritan announced that it received $8.6 million...
Samaritan Expands Revenue Opportunities With Marketing Authorization Approval for HIV Drug Amphocil in Cyprus
November 08, 2007 10:20 ET
|
Samaritan Pharmaceuticals, Inc.
LAS VEGAS, Nov. 8, 2007 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals, Inc. (AMEX:LIV) is pleased to announce that its subsidiary, Samaritan Pharmaceuticals Europe, S.A., has received notification...
Actors Studio's Anna Strasberg Joins Samaritan Advisory Board of Directors
November 06, 2007 10:38 ET
|
Samaritan Pharmaceuticals, Inc.
LAS VEGAS, Nov. 6, 2007 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals Inc., a developer of innovative drugs (AMEX:LIV), is honored to announce that Ms. Anna Strasberg has joined Samaritan's Advisory...
Samaritan Receives $8.6 Million Upfront Payment Under Commercialization Agreement for HIV Drug
October 16, 2007 11:31 ET
|
Samaritan Pharmaceuticals, Inc.
LAS VEGAS, Oct. 16, 2007 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals Inc. (AMEX:LIV), a developer of innovative drugs, announced today that, under a March 9, 2007 agreement with Pharmaplaz, Ltd., a...
Three Rivers Adds Territory of Ireland to Samaritan's Existing Exclusive Licensing Agreement to Market Amphocil in Greece and Cyprus
October 11, 2007 09:52 ET
|
Samaritan Pharmaceuticals, Inc.
LAS VEGAS, Oct. 11, 2007 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals Inc. (AMEX:LIV), a developer of innovative life saving drugs announced today it has signed an exclusive licensing and...
Samaritan Highlights Its Most Innovative HIV, Hepatitis C and Alzheimer's Drugs to Partner at Europe's Bio Partnering Conference
October 08, 2007 09:22 ET
|
Samaritan Pharmaceuticals, Inc.
LAS VEGAS, Oct. 8, 2007 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals Inc. (AMEX:LIV), a developer of innovative drugs, announced today its CEO Dr. Janet Greeson will highlight drugs in Samaritan's...